Results 141 to 150 of about 945,488 (321)

Ricinus Communis: Nutritional Importance, Health Benefits, and Industrial Applications

open access: yeseFood, Volume 7, Issue 1, February 2026.
The current paper summarizes the nutritional composition, phytochemistry, health benefits, safety studies, and applications of castor beans and their oil. Moreover, the diverse bioactive compounds, including saponins, emodins, terpenoids, anthraquinones, flavonoids, steroids, and alkaloids, exhibit therapeutic properties such as antioxidant, anticancer,
Hassan Raza   +13 more
wiley   +1 more source

Jaundice in a Returning Traveler—A Rare Manifestation of Mycoplasma pneumoniae Infection: Case Report

open access: yesClinical Practice and Cases in Emergency Medicine
Introduction: Cold agglutinin hemolytic anemia is a rare but serious complication of infections, including Mycoplasma pneumoniae. This case highlights the importance of considering infectious causes in patients with unexplained hemolysis.
Andrea Molin   +3 more
doaj   +1 more source

Context‐Dependent Roles of ANGPTL2‐Mediated Inflammaging in Tissue Homeostasis, Pathological Tissue Remodeling, and Longevity

open access: yesAging Cell, Volume 25, Issue 2, February 2026.
Yumoto et al. show that ANGPTL2 regulates inflammation, fibrosis, and tissue remodeling in high‐fat diet‐induced premature aging. ANGPTL2 deficiency shortens lifespan but reduces inflammation, revealing its context‐dependent and organ‐specific roles in maintaining homeostasis.
Shinsei Yumoto   +8 more
wiley   +1 more source

A Simple Microbiome in the European Common Cuttlefish, Sepia officinalis. [PDF]

open access: yes, 2019
The European common cuttlefish, Sepia officinalis, is used extensively in biological and biomedical research, yet its microbiome remains poorly characterized.
Abbo, Lisa   +9 more
core   +1 more source

P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY

open access: gold, 2023
Alexander Röth   +19 more
openalex   +1 more source

Thymoquinone Protects Against Cardiac Hypertrophy via PPAR‐γ/PI3K/Akt Pathway

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 3, February 2026.
ABSTRACT Thymoquinone (TQ), the principal active constituent of Nigella stativa, has demonstrated numerous biological properties and therapeutic effects on various diseases. However, its therapeutic potential against cardiac hypertrophy remains uncertain.
Rong‐bin Qiu   +10 more
wiley   +1 more source

Cold Agglutinin Disease

open access: yesHemato, 2022
The last 2 decades have seen great progress in understanding the pathogenesis of cold agglutinin disease (CAD) and development of effective therapies. Cold agglutinins can cause hemolytic anemia as well as peripheral circulatory symptoms such as acrocyanosis.
Berentsen, Sigbjørn   +4 more
openaire   +1 more source

Cryoglobulinemia: An update on classification, pathophysiology, clinical presentation, and management

open access: yesJournal of Internal Medicine, Volume 299, Issue 2, Page 196-215, February 2026.
Abstract Cryoglobulinemia (CG) is defined by the presence of serum immunoglobulins that precipitate below 37°C and redissolve upon rewarming. It is classified into three types based on immunoglobulin composition. Type I, a rare form, involves monoclonal IgM or IgG and is linked to lymphoproliferative disorders.
Anna Linda Zignego   +7 more
wiley   +1 more source

Glycan‐Mediated Grafting of Extracellular Matrix Proteins for Stable Biofunctionalization of Polystyrene Surfaces

open access: yesAdvanced Materials Interfaces, Volume 13, Issue 1, 7 January 2026.
We present a glycan‐mediated strategy for covalent grafting of extracellular matrix proteins onto polystyrene surfaces. This approach preserves protein bioactivity and enhances cell adhesion and viability. Using fibronectin and vitronectin, we demonstrate stable immobilization via glycosylation sites, offering a promising route for advanced ...
Mathilde Hindié   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy